Thursday Aug 28
Spectrum Pharmaceuticals: A Long-Term Bet
Spectrum, a small-cap biotechnology company, has five FDA-approved drugs generating revenue and a deep pipeline for hematology and oncology treatments.
Why Spectrum Fell on Beleodaq Approval but Will Rocket on Melphalan Approval
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Delcath Systems' (DCTH) Q2 2014 Results - Earnings Call Transcript
Good day, ladies and gentlemen and welcome to the Delcath Systems' Second Quarter 2014 Conference Call.
Delcath Reports 2014 Second Quarter Results
This compares with 22 treatments and six retreatments during the first seven months of 2013.
The glutathione synthesis inhibitor buthionine sulfoximine...
To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.